Table 1.
Clinicopathological parameters of UCB (n = 123).
| Parameter | Number (%) | |
|---|---|---|
| Sex | Male | 102 (82.9%) |
| Female | 21 (17.1%) | |
|
| ||
| Age | <60 years | 47 (38.2%) |
| ≥60 years | 76 (61.8%) | |
|
| ||
| Grade | Low grade | 31 (25.2%) |
| High grade | 92 (74.8%) | |
|
| ||
| Muscle invasion | Negative | 42 (34.1%) |
| Positive | 77 (62.6%) | |
| Indeterminate | 4 (3.3%) | |
|
| ||
| Pathological stage (pT) | T1 | 46 (37.4%) |
| T2 | 47 (38.2%) | |
| T3 | 17 (13.8%) | |
| T4 | 13 (10.6%) | |
|
| ||
| Nodal metastasis | Negative | 98 (79.7%) |
| Positive | 25 (20.3%) | |
|
| ||
| Distant metastasis | Negative | 110 (89.4%) |
| Positive | 13 (10.6%) | |
|
| ||
| Lymphovascular invasion | Negative | 101 (82.1%) |
| Positive | 22 (17.9%) | |
|
| ||
| Anatomical stage | I | 43 (35%) |
| II | 35 (28.5%) | |
| III | 14 (11.4%) | |
| IV | 31 (25.2%) | |
|
| ||
| Local disease recurrence | Negative | 83 (67.5%) |
| Positive | 40 (32.5%) | |
|
| ||
| Survival | Alive | 87 (70.7%) |
| Dead | 36 (29.3%) | |
T1: tumor invades subepithelial connective tissue; T2: tumor invades muscularis propria; T3: tumor invades perivesical tissue; T4: tumor invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, or abdominal wall; stage I: T1, N0, and M0; stage II: T2, N0, and M0; stage III: T3 or T4a, N0, and M0; stage IV: any T and N1-3 or M1.